Related Experiment Video
Updated: Jun 11, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
APC mutations dysregulate alternative polyadenylation in cancer
Austin M Gabel1,2,3,4, Andrea E Belleville1,2,3,5, James D Thomas1,2
1Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Background:
Alternative polyadenylation (APA) affects most human genes and is recurrently dysregulated in all studied cancers. However, the mechanistic origins of this dysregulation are incompletely understood.
Results:
We describe an unbiased analysis of molecular regulators of poly(A) site selection across The Cancer Genome Atlas and identify that colorectal adenocarcinoma is an outlier relative to all other cancer subtypes. This distinction arises from the frequent presence of loss-of-function APC mutations in colorectal adenocarcinoma, which are strongly associated with long 3' UTR expression relative to tumors lacking APC mutations. APC knockout similarly dysregulates APA in human colon organoids. By mining previously published APC eCLIP data, we show that APC preferentially binds G- and C-rich motifs just upstream of proximal poly(A) sites. Lastly, we find that reduced APC expression is associated with APA dysregulation in tumor types lacking recurrent APC mutations.
Conclusions:
As APC has been previously identified as an RNA-binding protein that preferentially binds 3' UTRs during mouse neurogenesis, our results suggest that APC promotes proximal poly(A) site use and that APC loss and altered expression contribute to pervasive APA dysregulation in cancers.
Insights
Loss of the APC gene disrupts alternative polyadenylation (APA) in colorectal cancer, leading to widespread gene expression changes. This finding reveals a new mechanism driving cancer development.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Alternative polyadenylation (APA) is a common gene regulation mechanism affecting most human genes.
- APA dysregulation is a hallmark of many cancers, but its underlying causes are not fully understood.
Purpose of the Study:
- To investigate the molecular regulators of poly(A) site selection across various cancer types.
- To understand the specific role of Adenomatous Polyposis Coli (APC) mutations in APA dysregulation, particularly in colorectal adenocarcinoma.
Main Methods:
- Unbiased analysis of poly(A) site selection regulators using The Cancer Genome Atlas (TCGA) data.
- Comparative analysis of APA in colorectal adenocarcinoma versus other cancer subtypes.
- Experimental validation using human colon organoids with APC knockout.
- Bioinformatic analysis of existing APC eCLIP data to identify binding motifs.
Main Results:
- Colorectal adenocarcinoma exhibits distinct APA patterns compared to other cancers, linked to frequent APC loss-of-function mutations.
- APC mutations are associated with longer 3' UTR expression, indicating a shift towards distal polyadenylation site usage.
- APC knockout in colon organoids recapitulates APA dysregulation observed in tumors.
- APC protein preferentially binds G- and C-rich motifs upstream of proximal poly(A) sites.
- Reduced APC expression correlates with APA dysregulation even in cancers without recurrent APC mutations.
Conclusions:
- APC acts as a regulator of proximal poly(A) site usage.
- APC loss or altered expression contributes significantly to the pervasive APA dysregulation observed in various cancers.
- These findings highlight APC's role in maintaining normal gene expression through APA regulation and its implications in cancer pathogenesis.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
RNA Editing

